Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Rockenstein

Showing results (111-120 of 197) with videos related to

Pageof 20
Sort By:
Journal of Neurovirology|January 24, 2013
Age-dependent molecular alterations in the autophagy pathway in HIVE patients and in a gp120 tg mouse model: reversal with beclin-1 gene transferJerel Fields, Wilmar Dumaop, Edward Rockenstein, et al.
Scientific Reports|December 29, 2018
Effects of Novel Calpain Inhibitors in Transgenic Animal Model of Parkinson's disease/dementia with Lewy bodiesGetaw Worku Hassen, Leo Kesner, Alfred Stracher, et al.
Acta Neuropathologica|March 3, 2009
Neurofibrillary and neurodegenerative pathology in APP-transgenic mice injected with AAV2-mutant TAU: neuroprotective effects of CerebrolysinKiren Ubhi, Edward Rockenstein, Edith Doppler, et al.
BMC Neuroscience|July 23, 2014
Cerebrolysin™ efficacy in a transgenic model of tauopathy: role in regulation of mitochondrial structureEdward Rockenstein, Kiren Ubhi, Margarita Trejo, et al.
Acta Neuropathologica|March 12, 2026
Editorial Expression of Concern: Neurofibrillary and neurodegenerative pathology in APP-transgenic mice injected with AAV2-mutant TAU: neuroprotective effects of CerebrolysinKiren Ubhi, Edward Rockenstein, Edith Doppler, et al.
Scientific Reports|April 14, 2026
Retraction Note: Effects of Novel Calpain Inhibitors in Transgenic Animal Model of Parkinson's disease/dementia with Lewy bodiesGetaw Worku Hassen, Leo Kesner, Alfred Stracher, et al.
BMC Neuroscience|November 19, 2008
Long-term neprilysin gene transfer is associated with reduced levels of intracellular Abeta and behavioral improvement in APP transgenic miceBrian Spencer, Robert A Marr, Edward Rockenstein, et al.
Neurotoxicity Research|March 4, 2016
The HIV Protein gp120 Alters Mitochondrial Dynamics in NeuronsValeria Avdoshina, Jerel Adam Fields, Paul Castellano, et al.
Scientific Reports|July 9, 2016
Longitudinal live imaging of retinal α-synuclein::GFP deposits in a transgenic mouse model of Parkinson's Disease/Dementia with Lewy BodiesDiana L Price, Edward Rockenstein, Michael Mante, et al.
Cell Reports|June 12, 2025
Antagonizing Neuronal Toll-like Receptor 2 Prevents Synucleinopathy by Activating AutophagyChangyoun Kim, Edward Rockenstein, Brian Spencer, et al.
Pageof 20

Showing results (111-120 of 197) with videos related to

Sort By:
Pageof 20
Journal of Neurovirology|January 24, 2013
Age-dependent molecular alterations in the autophagy pathway in HIVE patients and in a gp120 tg mouse model: reversal with beclin-1 gene transferJerel Fields, Wilmar Dumaop, Edward Rockenstein, et al.
Scientific Reports|December 29, 2018
Effects of Novel Calpain Inhibitors in Transgenic Animal Model of Parkinson's disease/dementia with Lewy bodiesGetaw Worku Hassen, Leo Kesner, Alfred Stracher, et al.
Acta Neuropathologica|March 3, 2009
Neurofibrillary and neurodegenerative pathology in APP-transgenic mice injected with AAV2-mutant TAU: neuroprotective effects of CerebrolysinKiren Ubhi, Edward Rockenstein, Edith Doppler, et al.
BMC Neuroscience|July 23, 2014
Cerebrolysin™ efficacy in a transgenic model of tauopathy: role in regulation of mitochondrial structureEdward Rockenstein, Kiren Ubhi, Margarita Trejo, et al.
Acta Neuropathologica|March 12, 2026
Editorial Expression of Concern: Neurofibrillary and neurodegenerative pathology in APP-transgenic mice injected with AAV2-mutant TAU: neuroprotective effects of CerebrolysinKiren Ubhi, Edward Rockenstein, Edith Doppler, et al.
Scientific Reports|April 14, 2026
Retraction Note: Effects of Novel Calpain Inhibitors in Transgenic Animal Model of Parkinson's disease/dementia with Lewy bodiesGetaw Worku Hassen, Leo Kesner, Alfred Stracher, et al.
BMC Neuroscience|November 19, 2008
Long-term neprilysin gene transfer is associated with reduced levels of intracellular Abeta and behavioral improvement in APP transgenic miceBrian Spencer, Robert A Marr, Edward Rockenstein, et al.
Neurotoxicity Research|March 4, 2016
The HIV Protein gp120 Alters Mitochondrial Dynamics in NeuronsValeria Avdoshina, Jerel Adam Fields, Paul Castellano, et al.
Scientific Reports|July 9, 2016
Longitudinal live imaging of retinal α-synuclein::GFP deposits in a transgenic mouse model of Parkinson's Disease/Dementia with Lewy BodiesDiana L Price, Edward Rockenstein, Michael Mante, et al.
Cell Reports|June 12, 2025
Antagonizing Neuronal Toll-like Receptor 2 Prevents Synucleinopathy by Activating AutophagyChangyoun Kim, Edward Rockenstein, Brian Spencer, et al.
Pageof 20